KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,151 | -96.9% | 1,605 | -95.8% | 0.00% | – |
| Q2 2023 | $68,460 | -97.6% | 38,246 | -94.8% | 0.00% | -100.0% |
| Q1 2023 | $2,839,805 | +64.2% | 730,027 | +43.5% | 0.00% | +100.0% |
| Q4 2022 | $1,729,216 | -47.9% | 508,593 | -16.3% | 0.00% | -50.0% |
| Q3 2022 | $3,316,000 | +56.8% | 607,396 | +29.5% | 0.00% | 0.0% |
| Q2 2022 | $2,115,000 | +124.5% | 469,019 | +267.1% | 0.00% | +100.0% |
| Q1 2022 | $942,000 | -51.8% | 127,780 | -58.0% | 0.00% | 0.0% |
| Q4 2021 | $1,955,000 | +38.1% | 304,098 | +25.0% | 0.00% | 0.0% |
| Q3 2021 | $1,416,000 | -64.7% | 243,248 | -37.5% | 0.00% | -50.0% |
| Q2 2021 | $4,015,000 | +13.6% | 389,026 | +15.8% | 0.00% | 0.0% |
| Q1 2021 | $3,535,000 | +1199.6% | 336,065 | +1810.9% | 0.00% | – |
| Q4 2020 | $272,000 | +14.8% | 17,587 | +8.1% | 0.00% | – |
| Q3 2020 | $237,000 | -90.8% | 16,271 | -88.0% | 0.00% | -100.0% |
| Q2 2020 | $2,578,000 | +97.2% | 136,105 | +100.1% | 0.00% | +100.0% |
| Q1 2020 | $1,307,000 | +148.5% | 68,032 | +147.7% | 0.00% | – |
| Q4 2019 | $526,000 | -57.4% | 27,471 | -78.6% | 0.00% | -100.0% |
| Q3 2019 | $1,234,000 | +686.0% | 128,193 | +389.5% | 0.00% | – |
| Q2 2019 | $157,000 | +14.6% | 26,187 | +11.6% | 0.00% | – |
| Q1 2019 | $137,000 | -88.8% | 23,455 | -82.1% | 0.00% | -100.0% |
| Q4 2018 | $1,226,000 | +573.6% | 130,817 | +1125.6% | 0.00% | – |
| Q3 2018 | $182,000 | -79.4% | 10,674 | -79.5% | 0.00% | -100.0% |
| Q2 2018 | $882,000 | +208.4% | 51,963 | +143.6% | 0.00% | – |
| Q1 2018 | $286,000 | +741.2% | 21,330 | +502.4% | 0.00% | – |
| Q4 2017 | $34,000 | +78.9% | 3,541 | +102.6% | 0.00% | – |
| Q3 2017 | $19,000 | +1800.0% | 1,748 | +1932.6% | 0.00% | – |
| Q2 2017 | $1,000 | -90.9% | 86 | -89.8% | 0.00% | – |
| Q1 2017 | $11,000 | +83.3% | 841 | +33.3% | 0.00% | – |
| Q4 2016 | $6,000 | 0.0% | 631 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | -75.0% | 631 | -82.2% | 0.00% | – |
| Q2 2016 | $24,000 | -84.7% | 3,543 | -79.9% | 0.00% | – |
| Q1 2016 | $157,000 | -38.7% | 17,588 | -9.0% | 0.00% | – |
| Q4 2015 | $256,000 | +130.6% | 19,319 | +83.2% | 0.00% | – |
| Q3 2015 | $111,000 | -71.9% | 10,548 | -27.2% | 0.00% | – |
| Q2 2015 | $395,000 | -14.5% | 14,496 | -4.0% | 0.00% | – |
| Q1 2015 | $462,000 | +34.7% | 15,094 | +64.6% | 0.00% | – |
| Q4 2014 | $343,000 | +1082.8% | 9,169 | +1019.5% | 0.00% | – |
| Q3 2014 | $29,000 | +480.0% | 819 | +680.0% | 0.00% | – |
| Q2 2014 | $5,000 | 0.0% | 105 | -37.1% | 0.00% | – |
| Q1 2014 | $5,000 | -94.3% | 167 | -95.6% | 0.00% | – |
| Q4 2013 | $88,000 | – | 3,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |